Page last updated: 2024-08-25

bendamustine hydrochloride and Leukemia, Lymphocytic

bendamustine hydrochloride has been researched along with Leukemia, Lymphocytic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Andreu-Ullrich, H; Beigelman-Aubry, C; Comte, D; Dumas, D; Eckerle, I; Fenwick, C; Gachoud, D; Germann, D; Guery, B; Infanti, L; Jaton, K; Mean, M; Monti, M; Pellaton, C; Prella, M; Rufer, N; Stadelmann, R; Stamm, GM; Vollenweider, P; Zimmerli, A1
Cheson, BD; Nair, KS; Penne, M; Sarraf Yazdy, M1

Other Studies

2 other study(ies) available for bendamustine hydrochloride and Leukemia, Lymphocytic

ArticleYear
Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Aged; Antibodies, Neutralizing; Antibodies, Viral; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bendamustine Hydrochloride; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Diabetes Mellitus, Type 2; Humans; Immunization, Passive; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunosuppression Therapy; Leukemia, Lymphoid; Male; Rituximab; SARS-CoV-2; Treatment Outcome

2021
Extended Follow-up of Patients Treated With Bendamustine for Lymphoid Malignancies.
    Clinical lymphoma, myeloma & leukemia, 2017, Volume: 17, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Female; Follow-Up Studies; Humans; Infections; Leukemia, Lymphoid; Lymphoma; Male; Middle Aged; Retreatment; Retrospective Studies; Treatment Outcome; Young Adult

2017